PMID- 9736697 OWN - NLM STAT- MEDLINE DCOM- 19981026 LR - 20211203 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 95 IP - 19 DP - 1998 Sep 15 TI - Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. PG - 11107-12 AB - Gene activation and cellular differentiation induced by interleukin-6 (IL-6) and transcription factor Stat3 are suppressed by several factors, including ionomycin, granulocyte/macrophage-colony-stimulating factor, and phorbol 12-myristate 13-acetate (PMA), that block IL-6-induced Stat3 activation. These inhibitory agents activate mitogen activated protein kinases (MAPKs), and thus the role of MAPKs in the mechanism of inhibition of Stat3 activation was investigated. Inhibition of IL-6-induced Stat3 activation by PMA and ionomycin was rapid (within 5 min) and did not require new RNA or protein synthesis. Inhibition of Stat3 DNA-binding activity and tyrosine phosphorylation by PMA, ionomycin, and granulocyte/macrophage-colony-stimulating factor was reversed when activation of the extracellular signal-regulated kinase (ERK) group of MAPKs was blocked by using specific kinase inhibitors. Expression of constitutively active MEK1, the kinase that activates ERKs, or overexpression of ERK2, but not JNK1, inhibited Stat3 activation. Inhibition of Stat3 correlated with suppression of IL-6-induction of a signal transducer and activator of transcription (STAT)-dependent reporter gene. In contrast to IL-6, activation of Stat3 by interferon-alpha was not inhibited. MEKs and ERKs inhibited IL-6 activation of Stat3 harboring a mutation at serine-727, the major site for serine phosphorylation, similar to inhibition of wild-type Stat3, and inhibited Janus kinases Jak1 and Jak2 upstream of Stat3 in the Jak-STAT-signaling pathway. These results demonstrate an ERK-mediated mechanism for inhibiting IL-6-induced Jak-STAT signaling that is rapid and inducible, and thus differs from previously described mechanisms for downmodulation of the Jak-STAT pathway. This inhibitory pathway provides a molecular mechanism for the antagonism of Stat3-mediated IL-6 activity by factors that activate ERKs. FAU - Sengupta, T K AU - Sengupta TK AD - Department of Medicine, Hospital for Special Surgery, Cornell University Graduate School of Medical Sciences New York, NY 10021, USA. FAU - Talbot, E S AU - Talbot ES FAU - Scherle, P A AU - Scherle PA FAU - Ivashkiv, L B AU - Ivashkiv LB LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Butadienes) RN - 0 (DNA-Binding Proteins) RN - 0 (Enzyme Inhibitors) RN - 0 (Flavonoids) RN - 0 (Interleukin-6) RN - 0 (Nitriles) RN - 0 (STAT3 Transcription Factor) RN - 0 (Trans-Activators) RN - 0 (U 0126) RN - 56092-81-0 (Ionomycin) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - EC 2.7.12.2 (MAP Kinase Kinase 1) RN - EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinases) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) RN - SJE1IO5E3I (2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one) SB - IM MH - Butadienes/pharmacology MH - Calcium-Calmodulin-Dependent Protein Kinases/*metabolism MH - Cell Line MH - DNA-Binding Proteins/analysis/*metabolism MH - Enzyme Activation/physiology MH - Enzyme Inhibitors/pharmacology MH - Flavonoids/pharmacology MH - Genes, Reporter/genetics MH - Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology MH - Interleukin-6/*pharmacology MH - Ionomycin/pharmacology MH - MAP Kinase Kinase 1 MH - *Mitogen-Activated Protein Kinase Kinases MH - Nitriles/pharmacology MH - Protein Serine-Threonine Kinases/antagonists & inhibitors MH - Protein-Tyrosine Kinases/antagonists & inhibitors/metabolism MH - STAT3 Transcription Factor MH - Tetradecanoylphorbol Acetate/pharmacology MH - Trans-Activators/*metabolism MH - Transfection/genetics PMC - PMC21603 EDAT- 1998/09/16 00:00 MHDA- 1998/09/16 00:01 PMCR- 1999/03/15 CRDT- 1998/09/16 00:00 PHST- 1998/09/16 00:00 [pubmed] PHST- 1998/09/16 00:01 [medline] PHST- 1998/09/16 00:00 [entrez] PHST- 1999/03/15 00:00 [pmc-release] AID - 0947 [pii] AID - 10.1073/pnas.95.19.11107 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11107-12. doi: 10.1073/pnas.95.19.11107.